Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Shares of obesity drug developers rise following study on Arena Pharmaceuticals' lorcaserin
Shares of obesity drug developers rise following study on Arena Pharmaceuticals' lorcaserin
Shares of obesity drug developers rise following study on Arena Pharmaceuticals' lorcaserin
Submitted by
admin
on July 15, 2010 - 10:19am
Source:
Yahoo/AP
News Tags:
obesity
Arena Pharmaceuticals
Qnexa
Contrave
Orexigen
Vivus
Headline:
Shares of obesity drug developers rise following study on Arena Pharmaceuticals' lorcaserin
Do Not Allow Advertisers to Use My Personal information
